Exclusive insight into pharma marketing, brand planning and commercialisation.
LATEST >
Q&A: Brand optimisation – Maximising pharma’s commercial impact
Intro: It’s not too late to close out 2023 with a bang. Pharma can capitalise on the remainder of the year and prep for...
Pharma compliance in a digital world
Rina Newton examines the European Federation of Pharmaceutical Industries...
What are the opportunities and challenges in the UK rare disease environment?
Following the the launch of England’s first Rare Diseases...
Making pharma marketing more meaningful
Joanna Stephenson, MD at PHD Marketing, explores how ‘green’ communications in pharma can be sincere but strategic. Across the diverse and exciting over-the-counter (OTC) pharma...
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
A true omnichannel approach in pharma: Replicating retail
What can pharma learn from retail when it comes to delivering a true omnichannel approach?
What a year or so we’ve all had since the...
How pharma can enhance its digital presence
With COVID-19 accelerating online migration this year, the pharma industry has had to embrace...
Creativity not commercialism is needed in healthcare
Phil Blackmore discusses why creativity is more important than commercialism in healthcare marketing.
In recent months...
ABPI Code and promotional emails
Dr Rina Newton, Managing Director of CompliMed, looks at the considerations relating to the...